华东医药：2020年半年度报告（英文版）.PDF

1、The Half Year Report 2020 of Huadong Medicine Co.,Ltd.1 Huadong Medicine Co.,Ltd.Half Year Report 2020 August 2020 The Half Year Report 2020 of Huadong Medicine Co.,Ltd.2 Section I.Important Declaration,Contents and Definitions The Board of Directors,Board of Supervisors,directors,supervisors and se

2、nior management of Huadong Medicine Co.,Ltd.(hereinafter referred to as the“Company”)hereby guarantee that the information presented in this half year report is authentic,accurate and complete and free of any false records,misleading statements or material omissions,and shall undertake individual an

3、d joint legal liabilities.Liang Lyu,the Companys legal representative and the officer in charge of accounting,and Renbo Qiu,head of accounting department(accounting supervisor)hereby declare and guarantee that the financial statements in this half year report are authentic,accurate and complete.All

4、directors have attended the Board of Directors meeting to review this half year report.The future plans,development strategies and other prospective statements in this half year report shall not be considered as substantial commitment of the Company to investors.Therefore,investors are kindly remind

5、ed to pay attention to possible investment risks.The company does not plan to distribute cash dividends,no bonus share will be issued;and no capital reserve will be converted to increase the share capital.The Half Year Report 2020 of Huadong Medicine Co.,Ltd.3 According to,if listed companies have C

6、hinese or other language versions of public notice,they should ensure the content of versions are the same.In case of discrepancy,the original Chinese version prevails.The Half Year Report 2020 of Huadong Medicine Co.,Ltd.4 Contents Section I.Important Declaration,Contents and Definitions.2 Section